CSIMarket
 


Nutriband Inc   (NTRB)
Other Ticker:  
 

Nutriband Inc 's Quick Ratio

NTRB's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




NTRB Quick Ratio (Oct 31 2022)
III. Quarter
(Jul 31 2022)
I. Quarter
(Apr 30 2022)
I. Quarter
(Oct 31 2021)
III. Quarter
(Jul 31 2021)
II. Quarter
Y / Y Current Liabilities Change -71.13 % -68.59 % -72.91 % -64.49 % 203.08 %
Y / Y Cash & cash equivalent Change 825.63 % 714.25 % 2538.7 % 2736.39 % 675.22 %
Quick Ratio MRQ 3.71 4.26 5.82 6.11 0.12
Overall Ranking # 997 # 1015 # 883 # # 1019
Seq. Current Liabilities Change -3.21 % 13.81 % -23.27 % -65.85 % 5.33 %
Seq. Cash & cash equivalent Change -15.79 % -16.61 % -26.88 % 1702.86 % -25.93 %



Quick Ratio third quarter 2022 Comment
Regardless of the sequential decrease in Current Liabilities, Quick Ratio detoriated to 3.71 below company average Quick Ratio.

Within Biotechnology & Pharmaceuticals industry 129 other companies have achieved higher Quick Ratio than Nutriband Inc in third quarter 2022. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are NTRB Segments?
See Quick Ratio NTRB on the trailing twelve month basis
Quick Ratio third quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 130
Healthcare Sector # 503
Overall Market # 997


Quick Ratio Statistics
High Average Low
18.18 2.46 0.01
(Jul 31 2018)   (Jan 31 2020)




Financial Statements
Nutriband Inc 's Current Liabilities $ 1 Millions Visit NTRB's Balance sheet
Nutriband Inc 's Cash & cash equivalent $ 3 Millions Visit NTRB's Balance sheet
Source of NTRB's Sales Visit NTRB's Sales by Geography


Cumulative Nutriband Inc 's Quick Ratio

NTRB's Quick Ratio for the trailling 12 Months

NTRB Quick Ratio

(Oct 31 2022)
III. Quarter
(Jul 31 2022)
I. Quarter
(Apr 30 2022)
I. Quarter
(Oct 31 2021)
III. Quarter
(Jul 31 2021)
II. Quarter
Y / Y Current Liabilities TTM Growth -71.13 % -68.59 % -72.91 % -64.49 % 203.08 %
Y / Y Cash & cash equivalent TTM Growth 825.63 % 714.25 % 2538.7 % 2736.39 % 675.22 %
Quick Ratio TTM 5 2.63 1.52 0.74 0.1
Total Ranking TTM # 690 # 1274 # 1825 # 2188 #
Seq. Current Liabilities TTM Growth -3.21 % 13.81 % -23.27 % -65.85 % 5.33 %
Seq. Cash & cash equivalent TTM Growth -15.79 % -16.61 % -26.88 % 1702.86 % -25.93 %


TTM Quick Ratio Comment
On the trailing twelve months basis NTRB Cash & cash equivalent average more than doubled by 825.63 % in III. Quarter year on year, while Current Liabilities decreased to $1 millions, this led to increase in in Nutriband Inc 's Quick Ratio to 5, Quick Ratio remained below NTRB average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 111 other companies have achieved higher Quick Ratio than Nutriband Inc . While Quick Ratio overall ranking has improved so far to 690, from total ranking in previous quarter at 1274.

Explain Quick Ratio?
What are NTRB Segments?
See Quick Ratio NTRB on the trailing twelve month basis

TTM Quick Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 112
Healthcare Sector # 433
Within the Market # 690


TTM Quick Ratio Statistics
High Average Low
4.71 0.99 0.03
(Oct 31 2022)   (Apr 30 2020)




Companies with similar Quick Ratio in the quarter ending Oct 31 2022, within Biotechnology & Pharmaceuticals Industry Quick RatioOct 31 2022 MRQ Cash & cash equivalentOct 31 2022 MRQ Current Liabilities
Scholar Rock Holding Corp  10.19 $ 343.655  Millions$ 33.736  Millions
Caribou Biosciences Inc   10.18 $ 293.369  Millions$ 28.814  Millions
Fennec Pharmaceuticals Inc   10.16 $ 29.752  Millions$ 2.927  Millions
Omega Therapeutics Inc   10.09 $ 148.346  Millions$ 14.698  Millions
Editas Medicine inc   9.92 $ 419.617  Millions$ 42.289  Millions
Passage Bio inc   9.89 $ 213.758  Millions$ 21.619  Millions
Pulse biosciences inc   9.88 $ 69.162  Millions$ 6.998  Millions
Humacyte Inc   9.59 $ 171.731  Millions$ 17.906  Millions
Tscan Therapeutics Inc   9.28 $ 137.306  Millions$ 14.799  Millions
Solid Biosciences Inc   9.17 $ 142.157  Millions$ 15.510  Millions
Invivyd Inc   9.08 $ 418.669  Millions$ 46.126  Millions
Surrozen Inc   9.06 $ 78.395  Millions$ 8.654  Millions
Revolution Medicines Inc   8.94 $ 655.013  Millions$ 73.271  Millions
Chase Corporation  8.93 $ 315.495  Millions$ 35.328  Millions
Dbv Technologies S a   8.87 $ 212.670  Millions$ 23.984  Millions
Tenaya Therapeutics Inc   8.44 $ 149.450  Millions$ 17.716  Millions
Inmune Bio Inc   8.33 $ 57.405  Millions$ 6.895  Millions
Inhibikase Therapeutics Inc   8.26 $ 26.534  Millions$ 3.213  Millions
Cytek Biosciences Inc   8.23 $ 341.523  Millions$ 41.494  Millions
Kodiak Sciences Inc   8.19 $ 537.395  Millions$ 65.600  Millions
Surface Oncology Inc   8.13 $ 146.350  Millions$ 17.992  Millions
Alpha Pro Tech Ltd   8.11 $ 15.517  Millions$ 1.914  Millions
Bioatla Inc   7.98 $ 178.120  Millions$ 22.327  Millions
Homology Medicines Inc  7.96 $ 201.074  Millions$ 25.252  Millions
Voyager Therapeutics Inc   7.92 $ 131.638  Millions$ 16.612  Millions
Curis Inc   7.81 $ 98.689  Millions$ 12.639  Millions
Vir Biotechnology Inc   7.58 $ 2,336.635  Millions$ 308.203  Millions
Rapid Micro Biosystems Inc   7.55 $ 114.894  Millions$ 15.212  Millions
Predictive Oncology Inc   7.32 $ 25.394  Millions$ 3.468  Millions
Senti Biosciences Inc   7.26 $ 114.940  Millions$ 15.837  Millions

Date modified: 2022-12-05T00:34:49+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SST's Profile

Stock Price

SST's Financials

Business Description

Fundamentals

Charts & Quotes

SST's News

Suppliers

SST's Competitors

Customers & Markets

Economic Indicators

SST's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071